136 related articles for article (PubMed ID: 32902029)
1. Polypharmacy and psychotropic polypharmacy in adults with intellectual disability: a cross-sectional total population study.
McMahon M; Hatton C; Bowring DL
J Intellect Disabil Res; 2020 Nov; 64(11):834-851. PubMed ID: 32902029
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
Deb S; Unwin G; Deb T
J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, patterns and factors associated with psychotropic use in older adults with intellectual disabilities in Ireland.
O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
J Intellect Disabil Res; 2017 Oct; 61(10):969-983. PubMed ID: 28639298
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of psychotropic medication use and association with challenging behaviour in adults with an intellectual disability. A total population study.
Bowring DL; Totsika V; Hastings RP; Toogood S; McMahon M
J Intellect Disabil Res; 2017 Jun; 61(6):604-617. PubMed ID: 28090687
[TBL] [Abstract][Full Text] [Related]
5. Psychotropic medication use in people living with severe and persistent mental illness in the Australian community: a cross-sectional study.
Hu J; McMillan SS; Theodoros T; Collins JC; El-Den S; O'Reilly CL; Wheeler AJ
BMC Psychiatry; 2022 Nov; 22(1):705. PubMed ID: 36380352
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Psychotropic Medication Use and Psychotropic Polypharmacy in Autistic Adults With or Without Intellectual Disability.
Yoshida K; Lunsky Y; Müller DJ; Desarkar P
J Autism Dev Disord; 2024 Jan; ():. PubMed ID: 38219270
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of potential drug-drug interactions in adults with intellectual disability.
McMahon M; Hatton C; Bowring DL; Hardy C; Preston NJ
J Intellect Disabil Res; 2021 Oct; 65(10):930-940. PubMed ID: 33988262
[TBL] [Abstract][Full Text] [Related]
8. Psychotropic medication use for adults and older adults with intellectual disability; selective review, recommendations and future directions.
Deutsch SI; Burket JA
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110017. PubMed ID: 32544599
[TBL] [Abstract][Full Text] [Related]
9. Predictors of Psychotropic Polypharmacy Among Outpatients With Psychiatric Disorders and Intellectual Disability.
Lunsky Y; Modi M
Psychiatr Serv; 2018 Feb; 69(2):242-246. PubMed ID: 29089006
[TBL] [Abstract][Full Text] [Related]
10. Management of psychotropic medications in adults with intellectual disability: a scoping review.
Costello A; Hudson E; Morrissey S; Sharma D; Kelly D; Doody O
Ann Med; 2022 Dec; 54(1):2486-2499. PubMed ID: 36120887
[TBL] [Abstract][Full Text] [Related]
11. Multimorbidity and psychotropic polypharmacy among participants with autism spectrum disorder with intellectual disability.
Espadas C; Ballester P; Londoño AC; Almenara S; Aguilar V; Belda C; Pérez E; Peiró AM
Psychiatry Res; 2020 Oct; 292():113321. PubMed ID: 32738553
[TBL] [Abstract][Full Text] [Related]
12. Pediatric Psychotropic Polypharmacy: An Evaluation of the Correlates and Prevalence Across Assessment Cycles in the National Health and Nutrition Examination Survey.
Bilsky S; Blumenthal H; Ramadan B; Lewis S; Leen-Feldner EW
J Child Adolesc Psychopharmacol; 2022 Oct; 32(8):416-425. PubMed ID: 36074100
[No Abstract] [Full Text] [Related]
13. Is higher psychotropic medication burden associated with involuntary treatment under the Mental Health Act? A four-year Australian cohort study.
Wheeler AJ; Hu J; Profitt C; McMillan SS; Theodoros T
BMC Psychiatry; 2020 Jun; 20(1):294. PubMed ID: 32527250
[TBL] [Abstract][Full Text] [Related]
14. Problem behaviours and psychotropic medication use in intellectual disability: a multinational cross-sectional survey.
Perry BI; Cooray SE; Mendis J; Purandare K; Wijeratne A; Manjubhashini S; Dasari M; Esan F; Gunaratna I; Naseem RA; Hoare S; Chester V; Roy A; Devapriam J; Alexander R; Kwok HF
J Intellect Disabil Res; 2018 Feb; 62(2):140-149. PubMed ID: 29349928
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study.
O'Dwyer M; Peklar J; McCallion P; McCarron M; Henman MC
BMJ Open; 2016 Apr; 6(4):e010505. PubMed ID: 27044582
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and patterns of anti-epileptic medication prescribing in the treatment of epilepsy in older adults with intellectual disabilities.
O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
J Intellect Disabil Res; 2018 Mar; 62(3):245-261. PubMed ID: 29314463
[TBL] [Abstract][Full Text] [Related]
17. Patterns of Mental Health Service Use During the Transition to Adulthood Among Autistic Adolescents and Young Adults.
Davis SA; Annis IE; Hughes PM; DeJong NA; Christian RB; Ruble LA; Thomas KC
Autism Adulthood; 2023 Dec; 5(4):366-373. PubMed ID: 38116058
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and factors associated with polypharmacy in Victorian adults with intellectual disability.
Haider SI; Ansari Z; Vaughan L; Matters H; Emerson E
Res Dev Disabil; 2014 Nov; 35(11):3071-80. PubMed ID: 25129201
[TBL] [Abstract][Full Text] [Related]
19. Psychotropic medicines' prevalence, patterns and effects on cognitive and physical function in older adults with intellectual disability in Ireland: longitudinal cohort study, 2009-2020.
Odalović M; Gorman A; Paul A; McCallion P; Burke É; MacLachlan M; McCarron M; Henman MC; Moran M; O'Connell J; Walsh M; Shankar R; Ryan C; O'Dwyer M
BJPsych Open; 2024 Feb; 10(2):e39. PubMed ID: 38297892
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Polypharmacy and Inappropriate Medication in Adults With Intellectual Disabilities in a Hospital Setting in Switzerland.
Lonchampt S; Gerber F; Aubry JM; Desmeules J; Kosel M; Besson M
Front Psychiatry; 2021; 12():614825. PubMed ID: 34248693
[No Abstract] [Full Text] [Related]
[Next] [New Search]
